Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 3/2021

09.07.2021 | Original Contributions

Feasibility of digital atrial fibrillation screening in an elderly population

The Ulm heart rhythm weeks

verfasst von: Ralf Birkemeyer, MD, Laura Maisch, Tillman Dahme, MD, Jochen Spieß, MD, Katharina Althaus, MD, Steffen Schneider, PhD, Ursula Ravens, MD, Doreen Haase, PhD, Ulrich Schotten, MD PhD

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Aims

Atrial fibrillation (AF) screening in risk populations has the potential to prevent strokes. The authors tested the feasibility of a digital program with initial photoplethysmographic (PPG) self-screening and cardiologist-attended electrocardiographic (ECG) confirmation of screen-positive cases.

Methods

Inhabitants of the city of Ulm aged ≥ 65 years were invited to participate. After digital consent, participants were given access to a smartphone application for 14 days of self-screening (two recordings per day recommended). Screen-positive participants without known AF were invited to present to a cardiologist for AF confirmation with a 14-day ECG event recorder. PPG recordings were first analyzed by algorithm using a combination of linear and non-linear methods. The quality of pathological (classified by algorithm) PPG and all ECG recordings were checked by a telecare service. Primary outcomes included adherence to the screening protocol defined as the proportion of participants performing at least 14 PPG recordings (or until documentation of absolute arrhythmia) and the proportion of pathological PPG and all ECG recordings rejected by the telecare center.

Results

A total of 215 participants registered. Of these, 204 (95%) performed at least one recording and 169 (79%) reached the performance target of two sufficient measurements per day; 75 PPG recordings were automatically classified as pathological by algorithm; 14 (19%) were rejected by the telecare service due to poor quality. Of the 12 participants with a suspected first diagnosis of AF, five visited a cardiologist as part of the study. Of 1090 ECG recordings obtained, 390 (36%) were qualified as non-diagnostic. AF was confirmed in three cases.

Conclusions

A digital AF screening program with initial self-screening and referral of screen-positive cases to a cardiologist-attended ECG-confirmation service is feasible with meaningful results in an elderly risk population. However, the availability of the target population of persons > 65 years of age for such a digital screening program appears to be limited despite extensive public relations activities.
Literatur
1.
Zurück zum Zitat Kirchhof P et al (2020) Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 383(14):1305–1316CrossRef Kirchhof P et al (2020) Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 383(14):1305–1316CrossRef
2.
Zurück zum Zitat EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342(8882):1255–1262CrossRef EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342(8882):1255–1262CrossRef
3.
Zurück zum Zitat Brasier N et al (2019) Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace 21(1):41–47CrossRef Brasier N et al (2019) Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace 21(1):41–47CrossRef
4.
Zurück zum Zitat Koenig N et al (2016) Validation of a new heart rate measurement algorithm for fingertip recording of video signals with smartphones. Telemed J E Health 22(8):631–636CrossRef Koenig N et al (2016) Validation of a new heart rate measurement algorithm for fingertip recording of video signals with smartphones. Telemed J E Health 22(8):631–636CrossRef
5.
Zurück zum Zitat Freedman B et al (2017) Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation 135(19):1851–1867CrossRef Freedman B et al (2017) Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation 135(19):1851–1867CrossRef
6.
Zurück zum Zitat Friberg L et al (2014) High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke 45(9):2599–2605CrossRef Friberg L et al (2014) High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke 45(9):2599–2605CrossRef
7.
Zurück zum Zitat Wachter R et al (2017) Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol 16(4):282–290CrossRef Wachter R et al (2017) Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol 16(4):282–290CrossRef
8.
Zurück zum Zitat Sanna T et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486CrossRef Sanna T et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486CrossRef
9.
Zurück zum Zitat Boriani G et al (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128(5):509–518.e2CrossRef Boriani G et al (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128(5):509–518.e2CrossRef
10.
Zurück zum Zitat Potpara TS et al (2013) A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 168(5):4744–4749CrossRef Potpara TS et al (2013) A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 168(5):4744–4749CrossRef
11.
Zurück zum Zitat Martinez C, Katholing A, Freedman SB (2014) Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost 112(2):276–286CrossRef Martinez C, Katholing A, Freedman SB (2014) Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost 112(2):276–286CrossRef
12.
Zurück zum Zitat Siontis KC et al (2016) Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm 13(7):1418–1424CrossRef Siontis KC et al (2016) Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm 13(7):1418–1424CrossRef
13.
Zurück zum Zitat Glotzer TV et al (2003) Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107(12):1614–1619CrossRef Glotzer TV et al (2003) Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107(12):1614–1619CrossRef
14.
Zurück zum Zitat Healey JS et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129CrossRef Healey JS et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129CrossRef
15.
Zurück zum Zitat Swiryn S et al (2016) Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation 134(16):1130–1140CrossRef Swiryn S et al (2016) Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation 134(16):1130–1140CrossRef
16.
Zurück zum Zitat Glotzer TV et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2(5):474–480CrossRef Glotzer TV et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2(5):474–480CrossRef
17.
Zurück zum Zitat Kirchhof P et al (2017) Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6) trial. Am Heart J 190:12–18CrossRef Kirchhof P et al (2017) Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6) trial. Am Heart J 190:12–18CrossRef
18.
Zurück zum Zitat Lopes RD et al (2017) Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial. Am Heart J 189:137–145CrossRef Lopes RD et al (2017) Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial. Am Heart J 189:137–145CrossRef
19.
Zurück zum Zitat Hindricks G et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373–498CrossRef Hindricks G et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373–498CrossRef
20.
Zurück zum Zitat Perez MV et al (2019) Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 381(20):1909–1917CrossRef Perez MV et al (2019) Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 381(20):1909–1917CrossRef
21.
Zurück zum Zitat Verbrugge FH et al (2019) Atrial fibrillation screening with photo-plethysmography through a smartphone camera. Europace 21(8):1167–1175CrossRef Verbrugge FH et al (2019) Atrial fibrillation screening with photo-plethysmography through a smartphone camera. Europace 21(8):1167–1175CrossRef
22.
Zurück zum Zitat Guo Y et al (2019) Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 74(19):2365–2375CrossRef Guo Y et al (2019) Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 74(19):2365–2375CrossRef
23.
Zurück zum Zitat Birkemeyer R et al (2020) A cost-effectiveness analysis model of preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany. Health Econ Rev 10(1):16CrossRef Birkemeyer R et al (2020) A cost-effectiveness analysis model of preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany. Health Econ Rev 10(1):16CrossRef
24.
Zurück zum Zitat Svennberg E et al (2015) Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 131(25):2176–2184CrossRef Svennberg E et al (2015) Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 131(25):2176–2184CrossRef
Metadaten
Titel
Feasibility of digital atrial fibrillation screening in an elderly population
The Ulm heart rhythm weeks
verfasst von
Ralf Birkemeyer, MD
Laura Maisch
Tillman Dahme, MD
Jochen Spieß, MD
Katharina Althaus, MD
Steffen Schneider, PhD
Ursula Ravens, MD
Doreen Haase, PhD
Ulrich Schotten, MD PhD
Publikationsdatum
09.07.2021
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 3/2021
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-021-00783-2

Weitere Artikel der Ausgabe 3/2021

Herzschrittmachertherapie + Elektrophysiologie 3/2021 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.